SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020958
Filing Date
2024-06-21
Accepted
2024-06-21 16:05:28
Documents
15
Period of Report
2024-06-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240614_8k.htm   iXBRL 8-K 35200
2 EXHIBIT 4.1 ex_688702.htm EX-4.1 14224
  Complete submission text file 0001437749-24-020958.txt   203439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20240620.xsd EX-101.SCH 3851
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240620_def.xml EX-101.DEF 13383
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240620_lab.xml EX-101.LAB 17550
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240620_pre.xml EX-101.PRE 13360
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20240614_8k_htm.xml XML 4654
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241060156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)